This provider averages 60 services per working day
Based on 150.5K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $24.1M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
Averaging 60 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 276% from 2014 to 2023.
70% of their billing comes from a single procedure code (J0178 — Injection, aflibercept, 1 mg).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 516% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $314.15 | $155.13 | 2.03x | $159.02 | $821.1K | 5.3K | 13 |
| 2015 | $296.74 | $92.87 | 3.20x | $203.87 | $267.5K | 2.9K | 16 |
| 2016 | $501.44 | $156.10 | 3.21x | $345.34 | $1.6M | 10.6K | 19 |
| 2017 | $554.84 | $173.04 | 3.21x | $381.80 | $2.1M | 12.2K | 18 |
| 2018 | $601.46 | $190.12 | 3.16x | $411.34 | $2.5M | 12.9K | 19 |
| 2019 | $697.08 | $218.96 | 3.18x | $478.12 | $3.4M | 15.6K | 22 |
| 2020 | $811.63 | $252.16 | 3.22x | $559.47 | $3.4M | 13.5K | 18 |
| 2021 | $838.47 | $260.76 | 3.22x | $577.71 | $3.7M | 14.4K | 17 |
| 2022 | $564.97 | $170.91 | 3.31x | $394.06 | $3.1M | 18.3K | 17 |
| 2023 | $219.01 | $68.58 | 3.19x | $150.43 | $3.1M | 45.0K | 15 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 22.6K | $16.7M | $737.14 | 2.82x |
| 67028 | Injection of drug into eye | 18.1K | $1.4M | $77.19 | 8.19x |
| J2778 | Injection, ranibizumab, 0.1 mg | 4.9K | $1.3M | $270.90 | 3.12x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 40.3K | $1.2M | $29.22 | 2.53x |
| 92012 | Established patient problem focused exam of visual system | 16.4K | $955.7K | $58.30 | 2.65x |
| 92134 | Imaging of retina | 27.3K | $767.7K | $28.15 | 3.53x |
| 92014 | Established patient complete exam of visual system | 4.2K | $345.3K | $81.56 | 2.68x |
| J9035 | Injection, bevacizumab, 10 mg | 5.4K | $309.5K | $57.05 | 1.43x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 2.2K | $248.4K | $112.42 | 2.45x |
| 67228 | Destruction of leaking blood vessels of retina using laser | 494 | $146.9K | $297.41 | 6.64x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 2.0K | $140.6K | $69.90 | 3.50x |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | 133 | $111.6K | $839.00 | 4.77x |
| 67210 | Destruction of growth of retina using a laser | 223 | $82.6K | $370.45 | 3.45x |
| 92250 | Photography of the retina | 2.0K | $79.7K | $39.38 | 3.17x |
| 67145 | Photocoagulation treatment to prevent detachment of retina | 173 | $61.4K | $354.70 | 3.40x |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | 45 | $39.4K | $876.24 | 4.79x |
| J3590 | Unclassified biologics | 812 | $28.2K | $34.77 | 2.12x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 175 | $27.4K | $156.43 | 2.56x |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 108 | $26.9K | $248.99 | 2.81x |
| 76512 | 2d ultrasound scan of eye tissue and structures | 514 | $24.7K | $47.97 | 5.21x |
This provider submits charges 3.17 times higher than what Medicare actually pays.
A markup ratio of 3.17x means for every $100 Medicare pays, this provider initially charges $317. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data